Fundraising Fox

Sixfold Bioscience

YC W18

London, GB · Founded 2018 · 27 employees · 5 known investors

sixfold.bio

Sixfold develops RNA delivery technology for the biotech industry. The company was founded by an oncologist and plant scientist and focuses on advancing RNA-based therapeutic approaches through proprietary delivery methods.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesGene TherapyNanomedicineDrug Deliveryin /sixfoldbioscience/@sixfold_bioycombinator.com ↗

Founders & leadership· Y Combinator alumni (W18)

GFGeorge Foot
George FootinFounder
APAnna Perdrix Rosell
Anna Perdrix RosellinFounder
TF
Tina FlatauDirector, Promoter
GW
George William FootExecutive Officer, Director, Promoter

Investors · 5

Competitors · 3

by search overlap

Companies competing with Sixfold Bioscience for the same Google search keywords, organic and paid, via search-intersection analysis.

Reported raises · per SEC filings

Form D private placements
$2.3MraisedAug 2021 · 13 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tina FlatauDirector, Promoter
  • Anna Perdrix RosellExecutive Officer, Director, Promoter
  • George William FootExecutive Officer, Director, Promoter
Offering amount
$2.3M
Amount sold
$2.3M
First sale
Feb 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news